Assignee
AMERICAN GENE TECH INT INC
US·35 granted patents·21 pending applications·276 citations·filing 2016–2025
Top patents by PatentIndex Score
56 records- 0197US10233464B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Mar 19, 2019·25 cites·14 claims
- 0297US10137144B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 27, 2018·28 cites·20 claims
- 0397US10036040B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·30 cites·19 claims
- 0497US10036038B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·25 cites·18 claims
- 0597US9914938B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Mar 13, 2018·34 cites·17 claims
- 0697US9834790B1Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Dec 5, 2017·33 cites·13 claims
- 0796US10420789B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Sep 24, 2019·13 cites·20 claims
- 0896US10023880B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 17, 2018·29 cites·11 claims
- 0995US10472649B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 12, 2019·14 cites·6 claims
- 1094US11090379B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2019·Granted Aug 17, 2021·5 cites·39 claims
- 1194US10772905B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Sep 15, 2020·6 cites·14 claims
- 1293US10888613B2Method of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2017·Granted Jan 12, 2021·5 cites·12 claims
- 1393US10767183B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2017·Granted Sep 8, 2020·7 cites·24 claims
- 1493US10494647B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Dec 3, 2019·5 cites·17 claims
- 1592US10428350B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Oct 1, 2019·7 cites·16 claims
- 1691US2025121051A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 1789US12370253B2Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Granted Jul 29, 2025·0 cites·10 claims
- 1888US11612649B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2021·Granted Mar 28, 2023·1 cites·94 claims
- 1988US11519006B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Dec 6, 2022·1 cites·16 claims
- 2088US11242527B1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2021·Granted Feb 8, 2022·1 cites·19 claims
- 2186US11534450B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2285US12410446B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·13 claims
- 2385US2024238406A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 2484US12403155B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 2, 2025·0 cites·16 claims
- 2584US11617760B2Safe lentiviral vectors for targeted delivery of multiple therapeutic moleculesAMERICAN GENE TECH INT INC·Filed 2021·Granted Apr 4, 2023·1 cites·14 claims
- 2684US11007209B2Safe lentiviral vectors for targeted delivery of multiple therapeutic moleculesAMERICAN GENE TECH INT INC·Filed 2019·Granted May 18, 2021·3 cites·12 claims
- 2784US2025121050A1Methods of producing cells resistant to hiv infectionAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 2884US2025042975A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 2984US2023241200A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3083US2025376685A1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
- 3182US11911458B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 27, 2024·1 cites·18 claims
- 3280US2024252615A1Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 3379US12359203B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2022·Granted Jul 15, 2025·0 cites·26 claims
- 3479US11980663B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2016·Granted May 14, 2024·1 cites·18 claims
- 3578US2024091340A1Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3677US2024141381A1Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3776US2024000822A1Safe lentiviral vectors for targeted delivery of multiple therapeutic moleculesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3874US12410445B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·17 claims
- 3974US2024115604A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 4074US2024141374A1On demand expression of exogenous factors in lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 4174US2025179150A1Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
- 4273US10975374B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2020·Granted Apr 13, 2021·0 cites·18 claims
- 4373US2023285480A1Viral vectors for treating parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 4472US12090200B2Methods of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2020·Granted Sep 17, 2024·0 cites·12 claims
- 4568US11352646B2Vector system for expressing regulatory RNAAMERICAN GENE TECH INT INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
- 4665US11820999B2Compositions and methods for treating phenylketonuriaAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 21, 2023·0 cites·6 claims
- 4763US11976292B2Non-integrating viral delivery system and methods related theretoAMERICAN GENE TECH INT INC·Filed 2016·Granted May 7, 2024·0 cites·12 claims
- 4863US2024279678A1On demand expression of exogenous factors in lymphocytes to treat hivAMERICAN GENE TECH INT INC·Filed 2021·Application pending·0 cites
- 4962US2021015868A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2019·Application pending·0 cites
- 5061US11583562B2Viral vectors for treating Parkinson's diseaseAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 21, 2023·0 cites·4 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AMERICAN GENE TECH INT INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →